---
schema_version: "secwatch.filing_event.v1"
accession: "0001299130-25-000072"
form_type: "8-K"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2025-03-27T23:59:59+00:00"
generated_at: "2026-05-24T03:43:17.121933+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# PacBio appoints Jim Gibson as CFO, effective March 31, 2025

## Summary
- Jim Gibson appointed CFO effective March 31, 2025; Christian Henry ceases as interim CFO.
- Gibson previously CFO at Sequoia and Willow Innovations; held exec roles at GoDaddy, Tesla, Apple, Netflix.
- Compensation: $500k base salary, 55% target bonus, 2M stock options, 1M RSUs with standard vesting.
- Severance provides 12 months salary and COBRA; change-in-control triggers full equity acceleration.
- PacBio targets positive cash flows by end of 2027, per press release announcing Gibson's hiring.

## SEC filing metadata
- accession: 0001299130-25-000072
- form_type: 8-K
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2025-03-27T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000072/0001299130-25-000072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000072/pacb-20250324.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001299130-25-000072
- JSON: https://secwatch.observer/filing/0001299130-25-000072.json
- Plain text: https://secwatch.observer/filing/0001299130-25-000072.txt

## Key facts
- Executive change
  Jim R. Gibson was appointed as Chief Financial Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On March 24, 2025, Pacific Biosciences of California, Inc. (the “Company”) entered into an offer letter with Jim R. Gibson to serve as its Chief Financial Officer. Mr. Gibson will be appointed as the Company’s Chief Financial Officer and principal financial officer effective as of as his first date of employment, which is anticipated to be March 31, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000072/0001299130-25-000072-index.htm
- Executive change
  Christian Henry changed role as President and Chief Executive Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..
  - Action: ceases serving as interim CFO
  - Role: President and Chief Executive Officer
  source text: Christian Henry, the Company’s President and Chief Executive Officer, who has been serving also as the Company’s interim Chief Financial Officer and principal financial officer since December 6, 2024 will cease serving as interim Chief Financial Officer and principal financial officer upon commencement of Mr. Gibson’s employment but will continue serving as the Company’s President and Chief Executive officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000072/0001299130-25-000072-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.